| Nevada                          | 98-0377767          |
|---------------------------------|---------------------|
| (State or Other Jurisdiction of | (IRS Employer       |
| Incorporation or Organization)  | Identification No.) |

| 18 Halivne street, Timrat Israel         | 23840      |
|------------------------------------------|------------|
| Israel                                   | (Zip Code) |
| (Address of Principal Executive Offices) |       |

| Large accelerated filer  ̈ | Accelerated filer o              |
|--------------------------------|----------------------------------|
| Non-accelerated filer o        | Smaller reporting company þ |

----

----

| PART I. FINANCIAL INFORMATION                                                                       |   | 4      |
|-----------------------------------------------------------------------------------------------------|--------|--------|
|                                                                                                |   |   |
| Item 1. Financial Statements                                                                        |   | 4      |
|                                                                                                |   |   |
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |   | 12     |
|                                                                                                |   |   |
| Item 3. Quantitative and Qualitative Disclosures about Market Risk                                  |   | 17     |
|                                                                                                |   |   |
| Item 4T. Controls and Procedures                                                                    |   | 17     |
|                                                                                                |   |   |
| PART II. OTHER INFORMATION                                                                          |   | 18     |
|                                                                                                |   |   |
| Item 1. Legal Proceedings                                                                           |   | 18     |
|                                                                                                |   |   |
| Item 1A. Risk Factors                                                                               |   | 18     |
|                                                                                                |   |   |
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds                                 |   | 18     |
|                                                                                                |   |   |
| Item 3. Defaults Upon Senior Securities                                                             |   | 18     |
|                                                                                                |   |   |
| Item 4. [Removed and Reserved]                                                                      |   | 18     |
|                                                                                                |   |   |
| Item 5. Other Information                                                                           |   | 18     |
|                                                                                                |   |   |
| Item 6. Exhibits                                                                                    |   | 18     |
|                                                                                                |   |   |
| Signatures                                                                                          |   | 18     |
|                                                                                                |   |   |
| Exhibit Index                                                                                       |   | 19     |
|                                                                                                |   |   |
| Certification of CEO Pursuant to Section 302                                                        |   |   |
|                                                                                                |   |   |
| Certification of CFO Pursuant to Section 302                                                        |   |   |
|                                                                                                |   |   |
| Certification Pursuant to U.S.C. Section 1350                                                       |   |   |

----

| Item 1. Financial Statements |
|------------------------------|
| Consolidated Balance Sheets  |

|                                                                                                                                                                                      |   | June 30 |       |   | December 31 |   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------|------------|--------|------------------|--------|
|                                                                                                                                                                                      |   | 2010         |       |   | 2009             |   |
|                                                                                                                                                                                      |   | $            |       |   | $                |   |
| Assets                                                                                                                                                                                    |   |         |       |   |             |   |
|                                                                                                                                                                                      |   |         |       |   |             |   |
| Current assets:                                                                                                                                                                           |   |         |       |   |             |   |
| Cash and cash equivalents                                                                                                                                                                 |   |         | 5,658      |   |             |   | 25,812 |   |
| Trade receivables                                                                                                                                                                         |   |         | 19,628     |   |             |   | 3,359 |   |
| Prepaid expenses and other current assets                                                                                                                                                 |   |         | 20,834     |   |             |   | 9,332 |   |
| Total current assets                                                                                                                                                                      |   |         | 46,120     |   |             |   | 38,503 |   |
|                                                                                                                                                                                      |   |         |       |   |             |   |   |   |
| Other non-current assets                                                                                                                                                                  |   |         | 3,339      |   |             |   | 2,762 |   |
| Property and equipment, net (Note 3)                                                                                                                                                      |   |         | 22,151     |   |             |   | 28,555 |   |
| Intangible assets, net (Note 4)                                                                                                                                                           |   |         | 68,507     |   |             |   | 74,507 |   |
| Total assets                                                                                                                                                                              |   |         | 140,117    |   |             |   | 144,327 |   |
|                                                                                                                                                                                      |   |         |       |   |             |   |   |   |
| Liabilities and stockholders' deficit                                                                                                                                                     |   |         |       |   |             |   |   |   |
|                                                                                                                                                                                      |   |         |       |   |             |   |   |   |
| Current liabilities:                                                                                                                                                                      |   |         |       |   |             |   |   |   |
| Shot term bank credit                                                                                                                                                                     |   |         | -          |   |             |   | 795 |   |
| Accounts payable and accrued liabilities                                                                                                                                                  |   |         | 329,117    |   |             |   | 285,693 |   |
| Total current liabilities                                                                                                                                                                 |   |         | 329,117    |   |             |   | 286,488 |   |
|                                                                                                                                                                                      |   |         |       |   |             |   |   |   |
| Convertible Promissory Note (Note 7)                                                                                                                                                      |   |         | 190,774    |   |             |   | 123,274 |   |
| Total liabilities                                                                                                                                                                         |   |         | 519,891    |   |             |   | 409,762 |   |
|                                                                                                                                                                                      |   |         |       |   |             |   |   |   |
| Commitments (Notes 5 and 8)                                                                                                                                                               |   |         |       |   |             |   |   |   |
|                                                                                                                                                                                      |   |         |       |   |             |   |   |   |
| Stockholders' deficiency:                                                                                                                                                                 |   |         |       |   |             |   |   |   |
| Common stock; $0.001 par value; 700,000,000 shares authorized; 68,824,268 and 67,824,268 shares issued and outstanding as of  June 30, 2010 and December 31, 2009, respectively |   |         | 68,823     |   |             |   | 67,823 |   |
| Additional paid-in capital                                                                                                                                                                |   |         | 3,652,342  |   |             |   | 3,616,670 |   |
| Deficit accumulated during the development stage                                                                                                                                          |   |         | (4,100,939 | )      |             |   | (3,949,928 | ) |
| Total stockholders' deficiency                                                                                                                                                            |   |         | (379,774   | )      |             |   | (265,435 | ) |
| Total liabilities and stockholders' deficiency                                                                                                                                            |   |         | 140,117    |   |             |   | 144,327 |   |

----

| Consolidated Statements of Operations |
|---------------------------------------|

|                                                                                  |   |                                           |       |   |                                         |   |       |                 |   |   | Cumulative         |   |
|---------------------------------------------------------------------------------------|--------|------------------------------------------------|------------|--------|----------------------------------------------|--------|------------|----------------------|--------|--------|--------------------|--------|
|                                                                                  |   |                                           |       |   |                                         |   |       |                 |   |   | fromInception      |   |
|                                                                                  |   |                                           |       |   |                                         |   |       |                 |   |   | (May 22,2002) |   |
|                                                                                  |   | Three months ended June 30 |       |   | Six months ended June 30 |   |       | to June 30 |   |
|                                                                                  |   | 2010                                           |       |   | 2009                                         |   |       | 2010                 |   |   | 2009               |   |   | 2010 |   |
|                                                                                  |   | $                                              |       |   | $                                            |   |       | $                    |   |   | $                  |   |   | $ |   |
|                                                                                  |   |                                           |       |   |                                         |   |       |                 |   |   |               |   |   |   |   |
| Revenues                                                                              |   |                                           | 39,003     |   |                                         |   | 7,373      |                 |   |   | 59,377             |   |   |   | 13,985 |   |   |   | 204,653 |   |
|                                                                                  |   |                                           |       |   |                                         |   |       |                 |   |   |               |   |   |   |   |   |   |   |   |   |
| Costs and expenses :                                                                  |   |                                           |       |   |                                         |   |       |                 |   |   |               |   |   |   |   |   |   |   |   |   |
|                                                                                  |   |                                           |       |   |                                         |   |       |                 |   |   |               |   |   |   |   |   |   |   |   |   |
| Research and development                                                              |   |                                           | 43,021     |   |                                         |   | 14,121     |                 |   |   | 60,132             |   |   |   | 32,696 |   |   |   | 586,962 |   |
| Sales and marketing                                                                   |   |                                           | -          |   |                                         |   | 4,598      |                 |   |   | 4,202              |   |   |   | 16,543 |   |   |   | 328,552 |   |
| General and administrative*                                                           |   |                                           | 76,670     |   |                                         |   | 76,723     |                 |   |   | 150,551            |   |   |   | 175,700 |   |   |   | 3,391,472 |   |
|                                                                                  |   |                                           |       |   |                                         |   |       |                 |   |   |               |   |   |   |   |   |   |   |   |   |
| Total operating expenses                                                              |   |                                           | 119,691    |   |                                         |   | 95,442     |                 |   |   | 214,885            |   |   |   | 224,939 |   |   |   | 4,306,986 |   |
|                                                                                  |   |                                           |       |   |                                         |   |       |                 |   |   |               |   |   |   |   |   |   |   |   |   |
| Operating loss                                                                        |   |                                           | (80,688    | )      |                                         |   | (88,069    | )                    |   |   | (155,508           | )      |   |   | (210,954 | ) |   |   | (4,102,333 | ) |
|                                                                                  |   |                                           |       |   |                                         |   |       |                 |   |   |               |   |   |   |   |   |   |   |   |   |
| Interest and other income (expenses), net                                             |   |                                           | 9,925      |   |                                         |   | (956       | )                    |   |   | 4,497              |   |   |   | (2,556 | ) |   |   | 45,310 |   |
|                                                                                  |   |                                           |       |   |                                         |   |       |                 |   |   |               |   |   |   |   |   |   |   |   |   |
| Loss before income tax                                                                |   |                                           | (70,763    | )      |                                         |   | (89,025    | )                    |   |   | (151,011           | )      |   |   | (213,510 | ) |   |   | (4,057,023 | ) |
| Income tax                                                                            |   |                                           | -          |   |                                         |   | -          |                 |   |   |               |   |   |   | - |   |   |   | 43,916 |   |
|                                                                                  |   |                                           |       |   |                                         |   |       |                 |   |   |               |   |   |   |   |   |   |   |   |   |
| Net loss                                                                              |   |                                           | (70,763    | )      |                                         |   | (89,025    | )                    |   |   | (151,011           | )      |   |   | (213,510 | ) |   |   | (4,100,939 | ) |
|                                                                                  |   |                                           |       |   |                                         |   |       |                 |   |   |               |   |   |   |   |   |   |   |   |   |
| Basic and diluted net loss per common share                                           |   |                                           | (0.00      | )      |                                         |   | (0.00      | )                    |   |   | (0.00              | )      |   |   | (0.00 | ) |   |   |   |   |
|                                                                                  |   |                                           |       |   |                                         |   |       |                 |   |   |               |   |   |   |   |   |   |   |   |   |
| Weighted average shares used in computing basic and diluted net loss per common share |   |                                           | 68,823,725 |   |                                         |   | 67,823,725 |                 |   |   | 68,823,725         |   |   |   | 67,823,725 |   |   |   | 51,820,331 |   |

| * | Includes $5,836, $8,218; $11,672, $16,464 and $1,094,919 in stock-based compensation to employees and non-employees for the three months periods, for the six months periods ended June 30, 2010, and 2009 and for the cumulative period from May 22, 2002 (date of inception) to June 30, 2010 respectively. |
|---|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Consolidated Statements of Cash Flows |
|---------------------------------------|

|                                                                        |   |                                         |     |   | Cumulative               |   |
|-----------------------------------------------------------------------------|--------|----------------------------------------------|----------|--------|--------------------------|--------|
|                                                                        |   |                                         |     |   | from inception      |   |
|                                                                        |   |                                         |     |   | (May 22, 2002) |   |
|                                                                        |   | Six months ended June 30 |     |   | to June 30     |   |
|                                                                        |   | 2010                                         |     |   | 2009                     |   |   | 2010 |   |
|                                                                        |   | $                                            |     |   | $                        |   |   | $ |   |
|                                                                        |   |                                         |     |   |                     |   |   |   |   |
| Cash flows from operating activities:                                       |   |                                         |     |   |                     |   |   |   |   |
| Net loss                                                                    |   |                                         | (151,011 | )      |                     |   | (213,510 | ) |   |   | (4,100,939 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities: |   |                                         |     |   |                     |   |   |   |   |   |   |   |
| Services contributed by officers                                            |   |                                         |     |   |                     |   | - |   |   |   | 3,500 |   |
| Depreciation and amortization                                               |   |                                         | 13,626   |   |                     |   | 28,995 |   |   |   | 176,334 |   |
| Stock-based compensation                                                    |   |                                         | 11,672   |   |                     |   | 16,464 |   |   |   | 1,094,919 |   |
| Changes in operating assets and liabilities:                                |   |                                         |     |   |                     |   |   |   |   |   |   |   |
| Decrease (Increase) in Trade receivables                                    |   |                                         | (16,269  | )      |                     |   | 3,806 |   |   |   | (19,628 | ) |
| Increase in Prepaid expenses and other current assets                       |   |                                         | (11,502  | )      |                     |   | (8,888 | ) |   |   | (20,834 | ) |
| Increase in Accounts payable and accrued liabilities                        |   |                                         | 43,424   |   |                     |   | 51,476 |   |   |   | 329,117 |   |
| Net cash used in operating activities                                       |   |                                         | (110,060 | )      |                     |   | (121,657 | ) |   |   | (2,537,531 | ) |
|                                                                        |   |                                         |     |   |                     |   |   |   |   |   |   |   |
| Cash flows from investing activities:                                       |   |                                         |     |   |                     |   |   |   |   |   |   |   |
| Decrease (increase) in long term deposit                                    |   |                                         | (577     | )      |                     |   | (7 | ) |   |   | (3,340 | ) |
| Purchase of property and equipment                                          |   |                                         | (1,222   | )      |                     |   | - |   |   |   | (146,991 | ) |
| Purchase of intangible assets                                               |   |                                         | -        |   |                     |   | - |   |   |   | (120,000 | ) |
| Net cash used in investing activities                                       |   |                                         | (1,799   | )      |                     |   | (7 | ) |   |   | (270,331 | ) |
|                                                                        |   |                                         |     |   |                     |   |   |   |   |   |   |   |
| Cash flows from financing activities:                                       |   |                                         |     |   |                     |   |   |   |   |   |   |   |
| Decrease in short term bank credit                                          |   |                                         | (795     | )      |                     |   | - |   |   |   | - |   |
| Increase in Convertible promissory note                                     |   |                                         | 67,500   |   |                     |   | 93,274 |   |   |   | 190,774 |   |
| Proceeds from issuance of common stock                                      |   |                                         | 25,000   |   |                     |   | - |   |   |   | 2,861,286 |   |
| Offering costs                                                              |   |                                         | -        |   |                     |   | - |   |   |   | (238,540 | ) |
| Net cash provided by financing activities                                   |   |                                         | 91,705   |   |                     |   | 93,274 |   |   |   | 2,813,520 |   |
| Net  (decrease) increase in cash and cash equivalents             |   |                                         | (20,154  | )      |                     |   | (28,390 | ) |   |   | 5,658 |   |
| Cash and cash equivalents at beginning of period                            |   |                                         | 25,812   |   |                     |   | 36,943 |   |   |   | - |   |
| Cash and cash equivalents at end of period                                  |   |                                         | 5,658    |   |                     |   | 8,553 |   |   |   | 5,658 |   |
| Non-cash activities                                                         |   |                                         |     |   |                     |   |   |   |   |   |   |   |
|                                                                        |   |                                         |     |   |                     |   |   |   |   |   |   |   |
| Supplemental disclosures of cash flow information:                          |   |                                         |     |   |                     |   |   |   |   |   |   |   |
|                                                                        |   |                                         |     |   |                     |   |   |   |   |   |   |   |
| Cash paid for taxes                                                         |   |                                         | -        |   |                     |   | - |   |   |   | - |   |

----

| ACRO Inc. (A Development Stage Company)                             |
|---------------------------------------------------------------------|
| Consolidated Financial Statements                                   |
| Notes to the Consolidated Financial Statements as of March 31, 2010 |

|   | A. | General |
|--------|----|---------|

|   | B. | Going concern |
|--------|----|---------------|

|   | A. | Basis of Presentation |
|--------|----|-----------------------|

|   | B. | Use of Estimates in the Preparation of Financial Statements |
|--------|----|-------------------------------------------------------------|

----

| ACRO Inc. (A Development Stage Company)                             |
|---------------------------------------------------------------------|
| Consolidated Financial Statements                                   |
| Notes to the Consolidated Financial Statements as of March 31, 2010 |

|   | C. | Principles of Consolidation |
|--------|----|-----------------------------|

|   | D. | Accounting Standards Codification |
|--------|----|-----------------------------------|

|   | E. | Initial Adoption of New Standards |
|--------|----|-----------------------------------|

|                                             |   | Estimated        |   |   |         |   |    |             |   |
|--------------------------------------------------|--------|------------------|--------|--------|--------------|--------|---------|------------------|--------|
|                                             |   | useful life |   |   | June 30 |   |    | December 31 |   |
|                                             |   | (years)          |   |   | 2010         |   |    | 2009             |   |
|                                             |   |             |   |   | $            |   |    | $                |   |
| Computer equipment                               |   |             | 3      |   |         |   | 14,709  |             |   |   | 13,487 |   |
| Production equipment                             |   |             | 3      |   |         |   | 122,341 |             |   |   | 122,341 |   |
| Furniture                                        |   |             | 7-15   |   |         |   | 7,924   |             |   |   | 7,924 |   |
| Leasehold improvements                           |   |             | (      | *)     |         |   | 2,017   |             |   |   | 2,017 |   |
|                                             |   |             |   |   |         |   | 146,991 |             |   |   | 145,769 |   |
| Less - Accumulated depreciation and amortization |   |             |   |   |         |   | 124,840 |             |   |   | 117,214 |   |
|                                             |   |             |   |   |         |   | 22,151  |             |   |   | 28,555 |   |

----

| ACRO Inc. (A Development Stage Company)                             |
|---------------------------------------------------------------------|
| Consolidated Financial Statements                                   |
| Notes to the Consolidated Financial Statements as of March 31, 2010 |

----

| ACRO Inc. (A Development Stage Company)                             |
|---------------------------------------------------------------------|
| Consolidated Financial Statements                                   |
| Notes to the Consolidated Financial Statements as of March 31, 2010 |

----

| ACRO Inc. (A Development Stage Company)                             |
|---------------------------------------------------------------------|
| Consolidated Financial Statements                                   |
| Notes to the Consolidated Financial Statements as of March 31, 2010 |

----

----

----

| Estimated Expenses through June 30, 2011 |   |
|------------------------------------------|--------|
|                                     |   |   |   |   |
| Product Research and Development         |   | $ | 50,000 |   |
|                                     |   |   |   |   |
| Sales and Marketing                      |   | $ | 50,000 |   |
|                                     |   |   |   |   |
| General and Administrative               |   | $ | 200,000 |   |
|                                     |   |   |   |   |
| Capital Expenditures                     |   | $ | - |   |
|                                     |   |   |   |   |
| Tax Expenses                             |   | $ | - |   |
|                                     |   |   |   |   |
| Total                                    |   | $ | 300,000 |   |

----

----

----

----

|   | ACRO INC.                          |   |                    |
|--------|------------------------------------|--------|-------------------------|
|   | (Registrant)                       |   |                    |
|   |                               |   |                    |
|   | By:                                |   |                    |
|   | s/ Gadi Aner                       |   | /s/Gabby Klausner       |
|   | Gadi Aner                          |   | Gabby Klausner          |
|   | President, Chief Executive Officer |   | Treasurer and           |
|   | & Director                     |   | Chief Financial Officer |
|   | Date: May 6, 2011                  |   | Date: May 6, 2011       |

----

| Number      | Description                                                                                                               |   | Method of Filing                                                                                                   |
|-------------|---------------------------------------------------------------------------------------------------------------------------|--------|--------------------------------------------------------------------------------------------------------------------|
|  (3)   |  Articles of Incorporation and By-laws                                                                               |   |                                                                                                               |
| 3.1         | Articles of Incorporation, as amended.                                                                                    |   | Incorporated by reference to Exhibit 3.1 to our registration statement on Form SB-2 filed November 21, 2003        |
|        |                                                                                                                      |   |                                                                                                               |
| 3.2         | Bylaws, dated February 25, 2005.                                                                                          |   | Incorporated by reference to Exhibit 3.1 to our current report on Form 8-K filed March 17, 2005 and March 21, 2005 |
|        |                                                                                                                      |   |                                                                                                               |
| 3.3         | Certificate of Change Pursuant to NRS 78.209 filed with the State of Nevada effective as of January 25, 2006.             |   | Incorporated by reference to Exhibit 3.3 to our annual report on Form 10-KSB filed March 28, 2007                  |
|        |                                                                                                                      |   |                                                                                                               |
| 3.4         | Certificate of Change Pursuant to NRS 78.209 filed with the State of Nevada effective as of October 25, 2006.             |   | Incorporated by reference to Exhibit 3.4 to our annual report on Form 10-KSB filed March 28, 2007                  |
|        |                                                                                                                      |   |                                                                                                               |
| 3.5         | Certificate of Change Pursuant to NRS 78.209 filed with the State of Nevada effective as of October 30, 2006.             |   | Incorporated by reference to Exhibit 3.5 to our annual report on Form 10-KSB filed March 28, 2007                  |
|   (10) |  Material Contracts                                                                                                  |   |                                                                                                               |
| 10.1        | Agreement and Plan of Merger for the Merger of ACRO Inc. with and into Medina International Corp., dated April 25, 2006.  |   | Incorporated by reference to Exhibit 10.2 to our current report on Form 8-K filed May 4, 2006                      |
|        |                                                                                                                      |   |                                                                                                               |
| 10.2        | Patent Purchase Agreement between the Registrant and Prof. Ehud Keinan, dated February 1, 2006.                           |   | Incorporated by reference to Exhibit 10.1 to our current report on Form 8-K filed February 3, 2006                 |
|        |                                                                                                                      |   |                                                                                                               |
| 10.3        | Consulting Agreement between the Registrant and BioTech Knowledge LLC, dated February 1, 2006.                            |   | Incorporated by reference to Exhibit 10.2 to our current report on Form 8-K filed February 3, 2006                 |
|        |                                                                                                                      |   |                                                                                                               |
| 10.4        | Letter of Agreement between the Registrant and BioTech Knowledge LLC, dated February 1, 2006.                             |   | Incorporated by reference to Exhibit 10.3 to our current report on Form 8-K filed February 3, 2006                 |
|        |                                                                                                                      |   |                                                                                                               |
| 10.5        | Advisory Board Agreement between the Registrant and Prof. Richard E. Lerner, dated May 31, 2006.                          |   | Incorporated by reference to Exhibit 99.2 to our current report on Form 8-K filed June 5, 2006                     |
|        |                                                                                                                      |   |                                                                                                               |
| 10.6        | Advisory Board Agreement between the Registrant and Prof. K. Barry Sharpless, dated September 28, 2006.                   |   | Incorporated by reference to Exhibit 10.8 to our annual report on Form 10-KSB filed March 28, 2007                 |
|        |                                                                                                                      |   |                                                                                                               |
| 10.7        | Consulting Agreement between Acrosec Ltd. and M.G NET Ltd., dated March 26, 2007                                          |   | Incorporated by reference to Exhibit 10.10 to our annual report on Form 10-KSB filed March 28, 2007                |
|        |                                                                                                                      |   |                                                                                                               |
| 10.8        | Cooperation and Licensing Agreement between the Registrant and Life Science Research Israel Ltd., dated October 28, 2007. |   | Incorporated by reference to Exhibit 10.11 to our annual report on Form 10-KSB filed March 13, 2008                |
|        |                                                                                                                      |   |                                                                                                               |
| 10.9        | Intellectual Property Assignment and Services Termination Agreement, dated March 30, 2009.                                |   | Incorporated by reference to Exhibit 10.12 to our annual report on Form 10-K filed March 30, 2009                  |
|        |                                                                                                                      |   |                                                                                                               |
| 10.10       | Convertible Promissory Note between the Registrant and BioTech Knowledge LLC, dated February 22, 2009.                    |   | Incorporated by reference to Exhibit 10.1 to our current report on Form 8-K filed February 23, 2009                |
|        |                                                                                                                      |   |                                                                                                               |
| 10.11       | Warrant between the Registrant and BioTech Knowledge LLC, dated February 22, 2009.                                        |   | Incorporated by reference to Exhibit 10.14 to our annual report on Form 10-K filed March 30, 2009                  |

----

| 10.12       | Convertible Promissory Note between the Registrant and BioTech Knowledge LLC, dated March 24, 2010.                                                                            |   | Incorporated by reference to Exhibit 10.12 to our annual report on Form 10-K filed March 29, 2010  |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|----------------------------------------------------------------------------------------------------|
|        |                                                                                                                                                                           |   |                                                                                               |
| 10.13       | Warrant between the Registrant and BioTech Knowledge LLC, dated March 24, 2010.                                                                                                |   | Incorporated by reference to Exhibit 10.13 to our annual report on Form 10-K filed March 29, 2010  |
|        |                                                                                                                                                                           |   |                                                                                               |
| 10.14       | The Registrant’s 2008 Israeli Share Option Plan                                                                                                                          |   | Incorporated by reference to Exhibit 10.1 to our current report on Form 8-K filed May 1, 2008      |
|        |                                                                                                                                                                           |   |                                                                                               |
| 10.15       | Finders Agreement between the Registrant and Siden Investment Inc. dated March 13, 2010.                                                                                       |   | Incorporated by reference to Exhibit 10.15 to our annual report on Form 10-K filed March 29, 2010  |
|        |                                                                                                                                                                           |   |                                                                                               |
| 10.16       | Promissory Note between the Registrant and Lindon Group, dated April 1, 2010.                                                                                                  |   | Incorporated by reference to Exhibit 10.16 to our quarterly report on Form 10-Q filed May 20, 2010 |
|        |                                                                                                                                                                           |   |                                                                                               |
|        |                                                                                                                                                                           |   |                                                                                               |
|   (31) |  Section 302 Certification                                                                                                                                                |   |                                                                                               |
| 31.1        | Rule 13a-14(a) Certification of Principal Executive Officer                                                                                                                    |   | Filed herewith                                                                                     |
|        |                                                                                                                                                                           |   |                                                                                               |
| 31.2        | Rule 13a-14(a) Certification of Principal Financial Officer.                                                                                                                   |   | Filed herewith                                                                                     |
|   (32) |  Section 906 Certification                                                                                                                                                |   |                                                                                               |
| 32.1        | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |   | Filed herewith                                                                                     |

----